FIVE YEARS RESULTS OF BIORESORBABLE VASCULAR SCAFFOLDS VERSUS CONVENTIONAL DRUG-ELUTING STENTS. A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS.
Anno:
2023
Background Bioresorbable vascular scaffolds (BVS) were designed to reduce the rate of late adverse events observed in conventional drug-eluting stents (DES) by dissolving once they have restored lasting patency. Objectives Compare the safety and efficacy after five years, of BVS versus DES in patients receiving percutaneous coronary intervention for coronary…